< Back to companies
Us2.ai

Us2.ai

Singapore, Singapore

Us2.ai uses machine learning to improve clinical decision making and cardiovascular research for clinical trials using echocardiography. Us2.ai connects institutions and imaging labs on a platform of ready-to-use automation tools for view classification, segmentation and federated learning across diverse, anonymous patient and disease cohorts.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2017
Website
us2.ai/

Categories

AI / MLCardiovascular Disease

Disease Areas

Technologies

Machine LearningAI/Machine LearningAI-driven AutomationClinical Decision Support Tools
Only accessible to MedStartr community members. Join now

What do you think of Us2.ai?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now